📰 Tim Pearson News
Page 6 - Tim Pearson News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Tim Pearson. Real-time updates on events, politics, business and more.
November 3, 2023
Korro will be focused on advancing a wholly owned portfolio of RNA editing programsPost-transaction cash of approximately $170 million expected to...
November 3, 2023
A campaign spokesperson said the Adams team returned the money from Bay Atlantic University employees because it had more than it could spend.
November 2, 2023
A first patient received samuraciclib plus Orserdu in a phase 2 trial, a treatment combination for some patients with HR-positive, HER2-negative metastatic breast cancer.
October 25, 2023
New York City implements a policy to deny migrants shelter and effectively evict them from the five boroughs.
October 25, 2023
The Department of Investigation inquiry focuses on a violent exchange that the adviser, Timothy Pearson, had with security guards at a migrant shelter.
October 23, 2023
NEW YORK — Scores of migrants were forced out Monday from an emergency shelter in Manhattan that was deemed unsafe by the FDNY, leaving them to return to the asylum seeker arrival center for a new place and fearful they could end up sleeping on the streets. Evictions were ordered at the shelter operating out of an old Touro College building on W. 31st St. near Eighth Ave. after the FDNY found ...
October 18, 2023
Tim Pearson, one of Mayor Eric Adams’ prominent aides, got into a tussle with security guards at a Manhattan migrant assistance center on Tuesday night, according to police sources.
October 5, 2023
Mitchell Newlin celebrated 10 years of service with Raybestos Powertrain on Wednesday. Newlin started with Raybestos Powertrain in 2013 as an operator. He has since held positions in inventory …
October 3, 2023
In this episode of Apple @ Work, I talk with Ben Greiner from Addigy and Tim Pearson from Creative Techs about the challenges around compliance in the Apple enterprise world.
September 11, 2023
The CDK12/13 inhibitor will be tested for efficacy and safety in patients with advanced solid tumors, such as breast, ovarian, and Ewing Sarcoma.